CLOV: Break of 8, time to meet it's fate?
XBI (Nasdaq biotech ETF) losing more key levels today and with other health care names already pretty saturated to the upside, could that mean CLOV isn't done falling?
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.